bluebird bio

Description

Develops one-time gene addition treatments for rare hematologic diseases, using patients' own cells and patient support services to help navigate therapy access.

Related

• BioCryst Pharmaceuticals ($BCRX)Develops oral small-molecule and injectable protein medicines for hereditary angioedema and other rare diseases, with physician-requested…
• Hansa Biopharma ABDevelops immunomodulating therapies using antibody-cleaving enzyme technology for patients with rare IgG-driven immunologic conditions, and…
• Liquidia ($LQDA)Develops therapies and lung drug-delivery technology for rare cardiopulmonary diseases, including pulmonary arterial hypertension,…
• Karyopharm Therapeutics ($KPTI)Develops and investigates oral nuclear export inhibitor cancer therapies for patients with cancer, especially in disease areas with high…
• Caribou Biosciences ($CRBU)Develops genome-edited allogeneic CAR-T cell therapies using CRISPR and chRDNA technology for patients with hematologic malignancies and…
• Aspen NeuroscienceDevelops autologous iPSC-derived cell therapies using a patient’s own cells, initially targeting Parkinson’s disease by replacing lost…
• Camurus ABDevelops innovative, long-acting treatments for severe and chronic diseases; used by patients and healthcare systems addressing unmet…
• AsimovBuilds an end-to-end genetic design platform combining synthetic biology and computational tools for biologics, cell therapy, and gene…
• Dyno TherapeuticsBuilds high-performance genetic technologies to improve AAV gene delivery for gene therapy, supporting therapeutic developers working on…
• Sana Biotechnology ($SANA)Builds engineered cell medicines that repair or control genes, or replace damaged cells, for patients with diseases including diabetes,…
• Cartesian Therapeutics ($RNAC)Develops clinical-stage mRNA cell therapies designed to treat autoimmune diseases, aiming to expand access to cell therapy for patients…
• Prime Medicine ($PRME)Develops one-time genetic therapies using prime editing to locate genome targets and replace faulty DNA segments for patients with diseases…